HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cletoquine

Also Known As:

2-((4-((7-chloro-4-quinolyl)amino)pentyl)amino)ethanol; cletochina; cletoquinum; desethylhydroxychloroquine

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Aminoquinolines: 29
        Chloroquine: 7498
        Hydroxychloroquine: 4560
        cletoquine: 7

Experts

1.	Alvarez, Jean Claude: 1 article (02/2022)
2.	Annane, Djillali: 1 article (02/2022)
3.	Davido, Benjamin: 1 article (02/2022)
4.	Etting, Isabelle: 1 article (02/2022)
5.	Larabi, Islam Amine: 1 article (02/2022)
6.	Moine, Pierre: 1 article (02/2022)
7.	Simon, Nicolas: 1 article (02/2022)
8.	Ge, Weihong: 1 article (07/2020)
9.	Luo, Xuemei: 1 article (07/2020)
10.	Peng, Ying: 1 article (07/2020)

Related Diseases

1.	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/01/2023 - "The aim of this study was to determine the factors associated with the concentrations of hydroxychloroquine (HCQ) and its major metabolite, desethylhydroxychloroquine (DHCQ), in patients with systemic lupus erythematosus (SLE). " 01/01/2017 - "To identify factors associated with blood concentrations of hydroxychloroquine (HCQ) and its major metabolite, N-desethylhydroxychloroquine (DHCQ), in patients with systemic lupus erythematosus (SLE; lupus) receiving long-term oral HCQ treatment. " 07/24/2020 - "Quantification of hydroxychloroquine (HCQ) and its two metabolites desethylchloroquine and desethylhydroxychloroquine in human blood can provide insight into the pharmacokinetic/pharmacodynamic characteristics of HCQ for the treatment of systemic lupus erythematosus (SLE), which is crucial for the optimization of the therapy. "
2.	COVID-19 01/01/2023 - "In addition to uncertainty in baseline HCQ PK parameters, it was not clear if disease-related consequences of SARS-CoV-2 infection/COVID-19 would be expected to impact the PK of HCQ and its primary metabolite desethylhydroxychloroquine (DHCQ). " 01/01/2023 - "To investigate the relationship between systemic exposure to hydroxychloroquine (HCQ) and its metabolite desethylhydroxychloroquine (DHCQ) and clinical outcome in severely ill patients treated with a standard oral dose regimen of HCQ during the first wave of COVID-19 in New York City. " 02/21/2022 - "We develop a population pharmacokinetic model for hydroxychloroquine (HCQ) and three of its metabolites (desethylhydroxychloroquine, Des HCQ; desethylchloroquine, DesCQ; and didesethylchloroquine, didesCQ) in COVID-19 patients in order to determine whether a pharmacokinetic (PK)/pharmacodynamic (PD) relationship was present. "
3.	Rheumatoid Arthritis 06/05/2017 - "Concentration of hydroxychloroquine (HCQ) and its metabolites, desethylhydroxychloroquine (DHCQ), desethylchloroquine (DCQ), and bisdesethylchloroquine (BDCQ), in capillary blood on VAMS sampler were compared to those in venous blood in rheumatoid arthritis patients. "

Related Drugs and Biologics

1.	Hydroxychloroquine (Plaquenil)
2.	desethylchloroquine
3.	N,N-dideethylchloroquine

Related Therapies and Procedures

1.	Therapeutics